Cargando…

A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients

Huntington’s disease (HD) is a progressive neurodegenerative disease. Involuntary movements, cognitive impairment and psychiatric disturbance are the major clinical manifestations, and gradual atrophy and selective neuronal loss in the striatum and cerebral cortex are the pathologic hallmarks. HD is...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Peng, Smith, Benjamin R., Huang, Eric S., Mahesh, Abhishek, Vonsattel, Jean Paul G., Petersen, Ashley J., Gomez-Pastor, Rocio, Ashe, Karen H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664763/
https://www.ncbi.nlm.nih.gov/pubmed/31358058
http://dx.doi.org/10.1186/s40478-019-0764-9
_version_ 1783439953172103168
author Liu, Peng
Smith, Benjamin R.
Huang, Eric S.
Mahesh, Abhishek
Vonsattel, Jean Paul G.
Petersen, Ashley J.
Gomez-Pastor, Rocio
Ashe, Karen H.
author_facet Liu, Peng
Smith, Benjamin R.
Huang, Eric S.
Mahesh, Abhishek
Vonsattel, Jean Paul G.
Petersen, Ashley J.
Gomez-Pastor, Rocio
Ashe, Karen H.
author_sort Liu, Peng
collection PubMed
description Huntington’s disease (HD) is a progressive neurodegenerative disease. Involuntary movements, cognitive impairment and psychiatric disturbance are the major clinical manifestations, and gradual atrophy and selective neuronal loss in the striatum and cerebral cortex are the pathologic hallmarks. HD is caused by expanded CAG trinucleotide repeats at the N-terminus of IT15 that encodes the huntingtin (HTT) protein, though the molecular mechanisms through which the mutant HTT (mHTT) exerts toxic effects remain obscure. Members of the caspase family, including caspase-2 (Casp2), play an important role in HD pathogenesis. Genetic ablation of Casp2 ameliorates cognitive and motor deficits of HD mice, though the molecular targets of Casp2 are still unclear. It is well established that the microtubule-associated protein tau potentiates cognitive dysfunction in a variety of neurodegenerative disorders, including HD. Our recent study indicates that Casp2-catalyzed tau cleavage at aspartate 314 (tau 2N4R isoform numbering system) mediates synaptotoxicity, cognitive deficits and neurodegeneration in cellular and mouse models of frontotemporal dementia; further, levels of Δtau314, the soluble, N-terminal cleavage product, are elevated in individuals with mild cognitive impairment and Alzheimer’s disease, compared with cognitively normal individuals. Here, we identified the presence of Δtau314 proteins in the striatum (caudate nucleus) and prefrontal cortex (Brodmann’s area 8/9) of human subjects, and showed that in both structures, levels of Casp2 and Δtau314 proteins correlate well, and both proteins are higher in HD patients than non-HD individuals. Our findings advance our understanding of the contribution of Casp2-mediated Δtau314 production to HD pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0764-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6664763
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66647632019-08-05 A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients Liu, Peng Smith, Benjamin R. Huang, Eric S. Mahesh, Abhishek Vonsattel, Jean Paul G. Petersen, Ashley J. Gomez-Pastor, Rocio Ashe, Karen H. Acta Neuropathol Commun Research Huntington’s disease (HD) is a progressive neurodegenerative disease. Involuntary movements, cognitive impairment and psychiatric disturbance are the major clinical manifestations, and gradual atrophy and selective neuronal loss in the striatum and cerebral cortex are the pathologic hallmarks. HD is caused by expanded CAG trinucleotide repeats at the N-terminus of IT15 that encodes the huntingtin (HTT) protein, though the molecular mechanisms through which the mutant HTT (mHTT) exerts toxic effects remain obscure. Members of the caspase family, including caspase-2 (Casp2), play an important role in HD pathogenesis. Genetic ablation of Casp2 ameliorates cognitive and motor deficits of HD mice, though the molecular targets of Casp2 are still unclear. It is well established that the microtubule-associated protein tau potentiates cognitive dysfunction in a variety of neurodegenerative disorders, including HD. Our recent study indicates that Casp2-catalyzed tau cleavage at aspartate 314 (tau 2N4R isoform numbering system) mediates synaptotoxicity, cognitive deficits and neurodegeneration in cellular and mouse models of frontotemporal dementia; further, levels of Δtau314, the soluble, N-terminal cleavage product, are elevated in individuals with mild cognitive impairment and Alzheimer’s disease, compared with cognitively normal individuals. Here, we identified the presence of Δtau314 proteins in the striatum (caudate nucleus) and prefrontal cortex (Brodmann’s area 8/9) of human subjects, and showed that in both structures, levels of Casp2 and Δtau314 proteins correlate well, and both proteins are higher in HD patients than non-HD individuals. Our findings advance our understanding of the contribution of Casp2-mediated Δtau314 production to HD pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0764-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-30 /pmc/articles/PMC6664763/ /pubmed/31358058 http://dx.doi.org/10.1186/s40478-019-0764-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liu, Peng
Smith, Benjamin R.
Huang, Eric S.
Mahesh, Abhishek
Vonsattel, Jean Paul G.
Petersen, Ashley J.
Gomez-Pastor, Rocio
Ashe, Karen H.
A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients
title A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients
title_full A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients
title_fullStr A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients
title_full_unstemmed A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients
title_short A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients
title_sort soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of huntington’s disease patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664763/
https://www.ncbi.nlm.nih.gov/pubmed/31358058
http://dx.doi.org/10.1186/s40478-019-0764-9
work_keys_str_mv AT liupeng asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT smithbenjaminr asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT huangerics asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT maheshabhishek asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT vonsatteljeanpaulg asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT petersenashleyj asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT gomezpastorrocio asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT ashekarenh asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT liupeng solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT smithbenjaminr solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT huangerics solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT maheshabhishek solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT vonsatteljeanpaulg solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT petersenashleyj solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT gomezpastorrocio solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients
AT ashekarenh solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients